Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Beyond Air Inc XAIR

Healthcare Medical Devices
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received United States Food and Drug Administration (FDA) approval for its first system, LungFit PH, for... see more

Recent & Breaking News (NDAQ:XAIR)

Beyond Air® Reports Financial Results for Third Quarter of Fiscal Year 2024

GlobeNewswire February 12, 2024

Beyond Air® Schedules Third Fiscal Quarter 2024 Financial Results Conference Call and Webcast

GlobeNewswire January 18, 2024

Beyond Cancer(TM) Phase 1 Study Clears Cohort 1 in Patients with Advanced Relapsed or Refractory Unresectable Primary or Metastatic Cutaneous or Subcutaneous Solid Tumors

GlobeNewswire December 27, 2023

Beyond Air® To Participate in the 35th Annual Piper Sandler Healthcare Conference

GlobeNewswire November 15, 2023

Beyond Air® Reports Financial Results for Second Quarter of Fiscal Year 2024

GlobeNewswire November 13, 2023

Beyond Cancer(TM) Presents Positive First-in-Human Clinical Data for Ultra-High Concentration Nitric Oxide (UNO) Therapy in Solid Tumors During the Society for Immunotherapy of Cancer (SITC) 2023 Annual Meeting

GlobeNewswire November 3, 2023

Beyond Air® Schedules Second Fiscal Quarter 2024 Financial Results Conference Call and Webcast

GlobeNewswire October 19, 2023

Beyond Air® To Participate in the Truist Securities BioPharma Symposium

GlobeNewswire October 17, 2023

Beyond Cancer(TM) Publishes Pre-Clinical Data in Cells Demonstrating that the Combination of Ultra-High Concentration Nitric Oxide (UNO) and Anti-mPD-1 Therapy Improves Tumor Regression Rates and Survival in Mice

GlobeNewswire October 17, 2023

Beyond Cancer(TM) Presents Positive Preclinical Data for Ultra-High Concentration Nitric Oxide (UNO) in Combination with Checkpoint Inhibitor Therapy During the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire October 16, 2023

Beyond Air® Receives Innovative Technology Contract from Vizient for LungFit®PH

GlobeNewswire October 16, 2023

Beyond Cancer(TM) Selected to Present Proffered Posters Discussing Data from the UNO Therapy Program at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

GlobeNewswire October 4, 2023

Beyond Air® To Participate in the Roth MKM 2023 Healthcare Opportunities Conference

GlobeNewswire October 2, 2023

Beyond Cancer(TM) to Present Initial Clinical Data for Ultra-High Concentration Nitric Oxide Therapy at the 2023 SITC Annual Meeting

GlobeNewswire September 27, 2023

Beyond Air® Announces Publication of Positive New Preclinical Data for the Treatment of Autism Spectrum Disorder

GlobeNewswire September 18, 2023

Beyond Air® and Getz Healthcare Enter Strategic Collaboration to Commercialize LungFit PH in Asia-Pacific Region

GlobeNewswire September 7, 2023

Beyond Air® To Participate in the 2023 Cantor Global Healthcare Conference

GlobeNewswire September 6, 2023

Beyond Air® Reports Financial Results for First Quarter of Fiscal Year 2024

GlobeNewswire August 10, 2023

Beyond Air® Announces Positive Preclinical Data on Role of Nitric Oxide in Autism Spectrum Disorder (ASD)

GlobeNewswire August 7, 2023

Beyond Air® To Participate in BTIG's 2023 Virtual Biotechnology Conference

GlobeNewswire August 1, 2023